Remove 3-main-trends-in-pharma-industry
article thumbnail

Tackling the complex development landscape of pain medicines

European Pharmaceutical Review

chronic neuropathic pain is at present, mainly managed with antidepressants… antiepileptic drugs… as well as opioids” Neuropathic pain affects over 400 million people worldwide, according to Hoba Therapeutics. In Europe, the prevalence of chronic neuropathic pain is estimated to be six–eight percent 1 of the general population.

article thumbnail

Our predictions for Pharma in 2023

Impetus Digital

At Impetus Digital, we get a first-hand look into evolving industry trends daily from our clients and their advisors, putting us in a unique position to make these predictions. The growing role of artificial intelligence (AI) and the importance of the “human aspect” throughout Pharma operations. Let’s dive in!

Pharma 94
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

What is the best way to develop an effective pharmaceutical marketing strategy?

eMediWrite

To find the best method for your pharma brand, combine opportunity, strategy, and action. For many of us, especially those in the pharmaceutical industry, the last 18 months have been a rollercoaster ride. In the pharmaceutical industry, there are a few key trends to keep an eye on. Increasing customer engagement.

article thumbnail

Microbiome therapies: a maturing movement

European Pharmaceutical Review

For World Microbiome Day on 27 June 2023, EPR put questions to Hervé Affagard, CEO and co-founder of MaaT Pharma and Jeffrey Silber, Chief Medical Officer of Vedanta Biosciences, to find out how the field is progressing and what innovations could transform future microbiome-based therapies. coli strains in the gut”. coli strains in the gut”.

article thumbnail

Digital clinical trials: Trends to watch in 2023

Pharmaceutical Technology

Overview of last year’s DCT activity North America dominates DCT landscape Analysis by GlobalData [3] shows that North America dominates industry and non-industry DCTs, with a total of 4,117 trials as of September 2022. The therapy area with the fourth highest percentage of digital trials is infectious diseases.

article thumbnail

Global Biopharma Launches in the New World Order

PM360

Biopharma blockbusters in the last 10 years show a disturbing trend. This new world order is marked by smaller, fragmented opportunities, increasing headwinds in high investment therapeutic areas, more complex customer groups requiring nuanced engagement models, and more compressed resources and investment from global pharma.

article thumbnail

Capital Equipment To MedTech Marketing With Omar Khateeb Part 1

Evolve Your Success

Capital equipment is one of the most exciting and thriving areas in medical sales right now. It brings cutting-edge technology together, from complex robotics and automation to SaaS models. Today, Omar Khateeb talks about his ventures in this area and how it changes the entire approach to MedTech marketing. Listen to the podcast here.